乙型肝炎病毒相关肝硬化患者的纤维化负荷与较差肾脏结局独立相关
本研究纳入1691例经影像学诊断的乙型肝炎病毒相关肝硬化且无基线慢性肾脏病的患者,这些患者在2012年3月至2018年8月期间接受瞬时弹性成像检查。在中位5.2年随访期间,60例(3.5%)患者发生复合肾脏结局。多变量Cox模型显示,肝脏硬度提示肝硬化(≥11.7 kPa)的患者较无显著肝纤维化(<7.9 kPa)的患者,较差肾脏结局风险高2.77倍(95%CI 1.16-6.63;P<.001)。
要点
- 在HBV相关肝硬化患者中,瞬时弹性成像评估的较高纤维化负荷与较差肾脏结局独立相关。
- 肝脏硬度≥11.7 kPa(提示肝硬化)者较<7.9 kPa(无显著肝纤维化)者肾脏结局风险高2.77倍(95%CI 1.16-6.63;P<.001)。
- 该关联在调整多种强混杂因素后仍然显著。
核心结论
- 瞬时弹性成像评估的较高纤维化负荷与HBV相关肝硬化患者的较差肾脏结局独立相关。
研究设计与样本
- 选取1691例经影像学诊断的HBV相关肝硬化且无基线慢性肾脏病、在2012年3月至2018年8月期间接受瞬时弹性成像的患者。
- 研究结局为复合终点:随访期间连续2次测量估算肾小球滤过率<60 mL/min/1.73 m²或蛋白尿(试纸≥1+)、估算肾小球滤过率下降50%或终末期肾病(开始慢性透析)或全因死亡。
主要发现
- 平均年龄53.4岁,男性1030例(60.9%)。
- 随访8379人年(中位5.2年)期间,60例(3.5%)患者发生研究结局。
- 多变量Cox模型显示,肝脏硬度≥11.7 kPa(提示肝硬化)者较<7.9 kPa(无显著肝纤维化)者,较差肾脏结局风险高2.77倍(95%CI 1.16-6.63;P<.001)。
- 该关联在调整多种强混杂因素后仍然显著。
关键数值与推荐
- 肝脏硬度≥11.7 kPa(提示肝硬化)者较<7.9 kPa(无显著肝纤维化)者,较差肾脏结局风险高2.77倍(95%CI 1.16-6.63;P<.001)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We investigated whether higher fibrotic burden was independently associated with poorer kidney outcomes in patients with hepatitis B virus (HBV)-related cirrhosis. METHODS: A total of 1691 patients with radiologically diagnosed HBV-related cirrhosis but without baseline chronic kidney disease (CKD) who underwent transient elastography (TE) between March 2012 and August 2018 were selected. The study outcome was the composite of development of incident CKD, defined as the occurrence of estimated glomerular filtration rate (eGFR) <60 mL/minute/1.73 m2 or proteinuria (≥1+ on dipstick test) on 2 consecutive measurements during follow-up, 50% decline in eGFR or onset of end-stage kidney disease (initiation of chronic dialysis), or all-cause mortality. RESULTS: The mean age was 53.4 years and 1030 (60.9%) patients were male. During 8379 person-years of follow-up (median 5.2 years), 60 (3.5%) patients experienced study outcomes. When stratified according to TE-defined fibrotic burden, multivariable Cox models revealed that risk of poorer kidney outcomes was 2.77-fold (95% confidence interval, 1.16-6.63; P < .001) higher in patients with liver stiffness range indicating cirrhosis (≥11.7 kPa), compared to those without significant liver fibrosis (<7.9 kPa). These associations remained significant even after adjusting for vigorous confounders. CONCLUSIONS: Higher fibrotic burden assessed using TE was independently associated with poorer kidney outcomes in patients with HBV-related cirrhosis.
引用
- Jung CY, Jung HY, Kim HW, et al. Fibrotic Burden in Patients With Hepatitis B Virus-Related Cirrhosis Is Independently Associated With Poorer Kidney Outcomes. J Infect Dis. 2024. PMID: 37470458. doi:10.1093/infdis/jiad273
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。